The new software package contains TruSeg and TruPath for use with the TruDi Navigation System and leverages a machine-learning algorithm
Acclarent, part of the Johnson & Johnson Medical Devices Companies, announced the US launch of its first-ever AI-powered ENT technology, designed to simplify surgical planning and provide real-time feedback during ENT navigation procedures. The new software package contains TruSeg and TruPath for use with the TruDi Navigation System and leverages a machine-learning algorithm to provide reliable and efficient image-guided preoperative planning and navigation for ENT procedures, like endoscopic sinus surgery.
TruDi has enabled software-guided navigation since its launch in 2018 and is designed for ENT surgeons to deliver real-time 3D guidance, anatomical mapping, and surgical insights to assist throughout ENT procedures.
“As one of the first ENTs to use TruDi, I immediately recognised the opportunity for this technology to help surgeons avoid unintended consequences and expand access to safe, minimally invasive, long-term solutions to patients in need of sinus surgery,” said Charles Ebert, Otolaryngologist and Professor, University of North Carolina Chapel Hill.
“The launch of this AI-powered software for TruDi is a leap forward in the evolution of image-guided ENT and skull base procedures,” said Jeff Hopkins, Worldwide President, Acclarent. “Acclarent continues to reimagine what’s possible with ENT navigation and TruDi continues to benefit patients and the ENT community through consistent accuracy, a simple workflow, and pioneering software functionality.”